Kathryn Pennel

17PUBLICATIONS
89CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 14, 2026
Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

|Apr 13, 2026
High Expression of PAPP-A Predicts Poor Outcomes in Oestrogen Receptor-Positive Breast Cancer Patients.

Zeanap Mabruk, Esme Bullock, Xue Xiao

|Jan 09, 2026
Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Lily V S Hillson, Ross K McMahon, Norman J Galbraith

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 04, 2025
WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer.

Bojie Cong, Evangelia Stamou, Kathryn Pennel

|May 15, 2025
Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer.

Walaiphorn Woraharn, Ashley McCulloch, Christopher Bigley

Pageof 3

Frequent Collaborators

12 joint publications

Joanne Edwards

4 joint publications

Antonia Roseweir

3 joint publications

Jean Quinn

3 joint publications

Owen J Sansom